News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
Jennifer Rogers, PhD, has been appointed head of statistical research at the global CRO, Phastar, where she will help grow the company’s statistical consultancy offerings and provide advice to current and potential customers.
Rogers’ expertise includes survival analysis, the analysis of recurrent events and joint modeling strategies that combine the two focus areas.
“As an academic, I always pursued methodological research driven by applied medical problems and it is my belief that a successful medical statistician should place themselves at the forefront of new statistical innovations that challenge standard practice where it becomes unsuitable,” said Rogers.
Working at Phastar, Rogers will have the opportunity to understand the current statistical challenges faced by the pharmaceutical industry, she said, “meaning that the research output being produced under my leadership will be timely and have the potential to make great improvements in the design, conduct, analysis, and reporting of clinical trials in industry.”
“By working closely with Phastar's clients on consultancy projects, I will be able to manage a research agenda that is driven by real-world problems,” she added.
“Coming from the University of Oxford, I also bring with me to Phastar a network of academic experts in the field of clinical trials and medical statistics, which I am hoping to develop into strategic links between Phastar and leading academic institutions.”